Published online Jan 27, 2026. doi: 10.4254/wjh.v18.i1.113247
Revised: September 11, 2025
Accepted: November 25, 2025
Published online: January 27, 2026
Processing time: 160 Days and 16 Hours
Hepatitis B Virus (HBV) remains a global public health challenge, affecting over 296 million people, many of whom are asymptomatic. Incidentally diagnosed carriers provide a critical window for early intervention and prevention. Under
To evaluate hematological parameters and HBV viral load in incidentally detected asymptomatic hepatitis B surface antigen positive patients during routine health screenings.
A cross-sectional observational study was conducted from June 2024 to March 2025 at Dr. D. Y. Patil Medical College, Hospital and Research Centre a tertiary care hospital in Pune, Maharashtra, India, involving 100 hepatitis B surface anti
Marked variations were detected in hemoglobin levels (P < 0.0001), percentage of neutrophils (P = 0.0006), percentage of lymphocytes (P = 0.0031), serum glutamic-oxaloacetic transaminase activity (P = 0.0013), and alanine aminotransferase levels (P = 0.0001) when comparing HBV-infected individuals with the control group. Con
Incidentally detected HBV infections present an opportunity for early disease detection. Hematological and viral markers can guide clinical decisions. Routine screening and contact tracing are essential strategies to control HBV transmission and progression.
Core Tip: A substantial proportion of hepatitis B virus infections remain undetected due to the asymptomatic nature of silent carriers. This study reveals that incidentally diagnosed hepatitis B surface antigen-positive individuals exhibit significant alterations in hematological and liver function parameters despite lacking clinical symptoms. Findings demonstrate a correlation between viral load and markers of hepatic injury, highlighting the need for vigilant laboratory monitoring. Early identification of subclinical liver involvement offers a critical window for intervention to prevent long-term complications such as cirrhosis and hepatocellular carcinoma. This work underscores the importance of integrating routine screening, hematological profiling, and virological assessment in public health strategies targeting hepatitis B virus control.
